Brand reminders, medical books, journals are like Freebies to doctors: ITAT denies Pfizer expense claim of Rs 11 crore Farhat Nasim21 Oct 2023 3:20 PM ISTMumbai: Noting that expenses done by pharma company Pfizer Limited on brand reminders and the purchase of medical books and journals were like...
USFDA nod for Pfizer Meningococcal vaccine Penbraya Ruchika Sharma21 Oct 2023 12:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PENBRAYA (meningococcal groups A, B, C, W and Y...
FDA approves etrasimod for moderate to severe Ulcerative Colitis Dr. Kamal Kant Kohli16 Oct 2023 11:15 AM ISTUSA: Etrasimod (Velsipity) has received approval from the US Food and Drug Administration (FDA) for adults with moderately to severely active...
EU medicines regulator recommends conditional marketing nod for Pfizer blood cancer therapy Ruchika Sharma15 Oct 2023 2:15 PM ISTNew York: The European Union medicines regulator has recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type...
Pfizer slashes full-year revenue forecast by 13 percent on lower COVID sales Ruchika Sharma15 Oct 2023 11:30 AM ISTNew York: Pfizer has slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to...
USFDA approves Pfizer Velsipity for adults with Ulcerative Colitis Ruchika Sharma14 Oct 2023 2:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily,...
Pfizer gets USFDA nod for Braftovi plus Mektovi for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer Ruchika Sharma14 Oct 2023 10:30 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib)...
USFDA finds no misconduct at trial sites for Pfizer Lyme disease vaccine Ruchika Sharma12 Oct 2023 11:33 AM ISTThe Boston-based company denied allegations of breach of clinical trial guidelines, and said the USFDA's inspection did not result in any Form 483...
Pfizer-BioNTech resolves Promosome patent lawsuit over COVID vaccine Ruchika Sharma7 Oct 2023 12:30 PM ISTPfizer and BioNTech denied the allegations and claimed Promosome had withheld information from the U.S. Patent Office when applying for the patent...
mRNA patent trial against BioNTech suspended by German court Ruchika Sharma29 Sept 2023 9:00 AM ISTDuesseldorf: A German court on Thursday suspended a patent trial against BioNTech over the use of mRNA technology in the COVID-19 vaccine developed by...
European Commission approves ritlecitinib for severe Alopecia areata Dr. Kamal Kant Kohli23 Sept 2023 9:45 AM ISTThe European Commission has authorized the marketing of ritlecitinib for treatment of severe alopecia areata for adolescents and adults . ...
AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion Ruchika Sharma22 Sept 2023 2:25 PM ISTAstraZeneca's Rare-Disease Unit
